Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy

키워드

참고문헌 (70)

1. Harris AL, "Hypoxia--a key regulatory factor in tumour growth", Nat Rev Cancer, 2, pp.38~47 (2002)
2. Wilson WR, "Targeting hypoxia in cancer therapy", Nat Rev Cancer, 11, pp.393~410 (2011)
3. Rankin EB, "The role of hypoxia-inducible factors in tumorigenesis", Cell Death Differ, 15, pp.678~685 (2008)
4. Triner D, "Hypoxia-inducible factors: a central link between inflammation and cancer", J Clin Invest, 126, pp.3689~3698 (2016)
5. Onnis B, "Development of HIF-1 inhibitors for cancer therapy", J Cell Mol Med, 13, pp.2780~2786 (2009)
6. Koh MY, "Passing the baton: the HIF switch", Trends Biochem Sci, 37, pp.364~372 (2012)
7. Höckel M, "Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects", J Natl Cancer Inst, 93, pp.266~276 (2001)
8. Vaupel P, "Hypoxia in cancer: significance and impact on clinical outcome", Cancer Metastasis Rev, 26, pp.225~239 (2007)
9. Bertout JA, "The impact of O2 availability on human cancer", Nat Rev Cancer, 8, pp.967~975 (2008)
10. Gu YZ, "Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha", Gene Expr, 7, pp.205~213 (1998)
11. Semenza GL, "The hypoxic tumor microenvironment: a driving force for breast cancer progression", Biochim Biophys Acta, 1863, pp.382~391 (2016)
12. Keith B, "HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression", Nat Rev Cancer, 12, pp.9~22 (2011)
13. Duan C, "Hypoxia-inducible factor 3 biology: complexities and emerging themes", Am J Physiol Cell Physiol, 310, pp.C260~C269 (2016)
14. Yamashita K, "Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300", CBP, 2001, pp.276, 12645~12653
15. Bruick RK, "A conserved family of prolyl-4-hydroxylases that modify HIF", Science, 294, pp.1337~1340 (2001)
16. Agnieszka Loboda, "HIF-1 and HIF-2 Transcription Factors - Similar but Not Identical", Molecules and Cells, 29(5), pp.435~442 (2010), 한국분자세포생물학회
17. Zhao D, "Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α", EGFR pathway in hepatocellular carcinoma cells, 2014, pp.26, 1030~1039
18. Holmquist-Mengelbier L, "Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma:HIF-2alpha promotes an aggressive phenotype", Cancer Cell, 10, pp.413~423 (2006)
19. Masoud GN, "HIF-1α pathway: role, regulation and intervention for cancer therapy", Acta Pharm Sin B, 5, pp.378~389 (2015)
20. Unwith S, "The potential role of HIF on tumour progression and dissemination", Int J Cancer, 136, pp.2491~2503 (2015)
21. Xia Y, "Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors", Eur J Med Chem, 49, pp.24~40 (2012)
22. 양연주, "Hypoxia Induces Epithelial-Mesenchymal Transition in Follicular Thyroid Cancer: Involvement of Regulation of Twist by Hypoxia Inducible Factor-1α", Yonsei Medical Journal, 56(6), pp.1503~1514 (2015), 연세대학교의과대학
23. Peng G, "Hypoxia-inducible factors in cancer stem cells and inflammation", Trends Pharmacol Sci, 36, pp.374~383 (2015)
24. Samanta D, "Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells", Proc Natl Acad Sci U S A, 111, pp.E5429~E5438 (2014)
25. Rohwer N, "Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways", Drug Resist Updat, 14, pp.191~201 (2011)
26. Wigerup C, "Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer", Pharmacol Ther, 164, pp.152~169 (2016)
27. Warfel NA, "HIF-1 signaling in drug resistance to chemotherapy", Curr Med Chem, 21, pp.3021~3028 (2014)
28. Balamurugan K, "HIF-1 at the crossroads of hypoxia, inflammation, and cancer", Int J Cancer, 138, pp.1058~1066 (2016)
29. Kim JW, "Effects of hypoxia on tumor metabolism", Cancer Metastasis Rev, 26, pp.291~298 (2007)
30. Jeong W, "Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors", Cancer Chemother Pharmacol, 73, pp.343~348 (2014)
31. Greenberger LM, "A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth", Mol Cancer Ther, 7, pp.3598~3608 (2008)
32. Coltella N, "Synergistic leukemia eradication by combined treatment with retinoic acid and HIF inhibition by EZN-2208 (PEG-SN38) in preclinical models of PML-RARα and PLZF-RARα-driven leukemia", Clin Cancer Res, 21, pp.3685~3694 (2015)
33. Rapisarda A, "Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications", Cancer Res, 64, pp.1475~1482 (2004)
34. Lee K, "A novel approach to cancer therapy using PX-478as a HIF-1α inhibitor", Arch Pharm Res, 34, pp.1583~1585 (2011)
35. Liu X, "Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation", Nucleic Acids Res, 43, pp.5081~5098 (2015)
36. Ma L, "2-methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1and -2", Cancer Lett, 355, pp.96~105 (2014)
37. Narita T, "Identification of a novel small molecule HIF-1alpha translation inhibitor", Clin Cancer Res, 15, pp.6128~6136 (2009)
38. Lee SH, "A group of novel HIF-1α inhibitors, glyceollins, blocks HIF-1α synthesis and decreases its stability via inhibition of the PI3K", AKT, J Cell Physiol, pp.2015, 230[DOI]
39. Hu N, "BMP9-regulated angiogenic signaling plays an important role in the osteogenic differentiation of mesenchymal progenitor cells", J Cell Sci, 126(Pt 2), pp.532~541 (2013)
40. Newman B, "HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells", Cancer Res, 72, pp.4551~4561 (2012)
41. Ibrahim NO, "Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors", Cancer Res, 65, pp.11094~11100 (2005)
42. Kubo T, "Bisphenol A, an environmental endocrine-disrupting chemical, inhibits hypoxic response via degradation of hypoxia-inducible factor 1alpha (HIF-1alpha): structural requirement of bisphenol A for degradation of HIF-1alpha", Biochem Biophys Res Commun, 318, pp.1006~1011 (2004)
43. Ellinghaus P, "BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I", Cancer Med, 2, pp.611~624 (2013)
44. Dat NT, "Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxiainducible factor-1", J Nat Prod, 70, pp.1093~1097 (2007)
45. Nakazawa MS, "Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth", Nat Commun, 7, pp.10539~ (2016)
46. Lee K, "LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1alpha via upregulation of VHL in a colon cancer cell line", Biochem Pharmacol, 80, pp.982~989 (2010)
47. Cui XY, "Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer", J Thromb Haemost, 14, pp.387~396 (2016)
48. Raninga PV, "Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma", Oncotarget, 6, pp.15410~15424 (2015)
49. Jordan BF, "The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imaging", Clin Cancer Res, 11(2 Pt 1), pp.529~536 (2005)
50. Miranda E, "A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells", J Am Chem Soc, 135, pp.10418~10425 (2013)
51. Scheuermann TH, "Allosteric inhibition of hypoxia inducible factor-2 with small molecules", Nat Chem Biol, 9, pp.271~276 (2013)
52. Scheuermann TH, "Artificial ligand binding within the HIF2alpha PASB domain of the HIF2 transcription factor", Proc Natl Acad Sci U S A, 106, pp.450~455 (2009)
53. Lee K, "Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization", Proc Natl Acad Sci U S A, 106, pp.17910~17915 (2009)
54. Kong D, "Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity", Cancer Res, 65, pp.9047~9055 (2005)
55. Yu W, "Loss of SIRT3 provides growth advantage for B cell malignancies", J Biol Chem, 291, pp.3268~3279 (2016)
56. Young RM, "Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism", J Biol Chem, 283, pp.16309~16319 (2008)
57. Sun X, "Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy", Gene Ther, 8, pp.638~645 (2001)
58. Bertozzi D, "The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells", Mol Cancer Ther, 13, pp.239~248 (2014)
59. Fu B, "Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis", Mol Cancer Ther, 6, pp.220~226 (2007)
60. Isaacs JS, "Hsp90 regulates a von Hippel Lindau-independent hypoxiainducible factor-1 alpha-degradative pathway", J Biol Chem, 277, pp.29936~29944 (2002)
61. Bohonowych JE, "Comparative analysis of novel and conventional Hsp90inhibitors on HIF activity and angiogenic potential in clear cell renal cell carcinoma: implications for clinical evaluation", BMC Cancer, 11, pp.520~ (2011)
62. Hutt DM, "The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition", PLoS One, 9, pp.e106224~ (2014)
63. Lee K, "Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumorinduced mobilization of circulating angiogenic cells", Proc Natl Acad Sci U S A, 106, pp.2353~2358 (2009)
64. Kung AL, "Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway", Cancer Cell, 6, pp.33~43 (2004)
65. Minegishi H, "Discovery of indenopyrazoles as a new class of hypoxia inducible factor (HIF)-1inhibitors", ACS Med Chem Lett, 4, pp.297~301 (2013)
66. Santos AI, "Stimulation of neural stem cell proliferation by inhibition of phosphodiesterase 5", Stem Cells Int, 2014, pp.878397~ (2014)
67. Moreno-Manzano V, "FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status", J Biol Chem, 285, pp.1333~1342 (2010)
68. Koh MY, "The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion", Cancer Res, 71, pp.4015~4027 (2011)
69. Seton-Rogers S, "Hypoxia: HIF switch", Nat Rev Cancer, 11, pp.391~ (2011)
70. Chau NM, "Identification of novel small molecule inhibitors of hypoxiainducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors", Cancer Res, 65, pp.4918~4928 (2005)

관련 논문AI추천